dont get me wrong , its still got decent fundamentals, but the ratios all look much worse post all the acquisitions and dilution
If profit can consistently grow from now on, the ROE, ROIC, ROA n EPS will all look better and better within a couple of years
But the ratios looked unblievable till recently - thats why every1 loved this company . Look at the historic Retuen on Equity and Return on Invested Capital n Return on Assets - - Unbelievable!
Now these ratios have all hit the lower end of what buffet or traditional fundamental analysts expect, and if profit FALLS from now on, that wont be good for all the fundamentals.
This company made great returns on both equity AND the return was great on the debt PLUS the equity
they borrowed money, but the return on those borrowed funds was awesome!
ROE and ROIC looked amazing
But earnings are exposed to fertiliser Prices and exploives which are linked to demand and commodity boom
So earnings in this coy are more volatile thru the business cycle! i.e over the long term business cycle.
this volatility in earnings means this coy isnt as 'safe' as most ppl like to think!
Now that we are in a depressed point of the business cycle lets see what kind of fundanmental numbers we might get for EPS, ROE and ROIC and ROA
It was a great boom stock with amazing figures, but in the bust end of the biz cycle its fundamentals can look pretty weak
i.e if NPAT goes down due to lower demand, thisll affect all the key buffet ratios which are on the edge as we speak due to recent dliutions.
Still a good comapany, but it was a little too hyped up - looks very good in a boom, but looks much weaker in a bust. its coz earnings are heavily linked to volatility in commodity ps and overall demand
- Forums
- ASX - By Stock
- IPL
- fundamental analysis shows ipl now weaker
fundamental analysis shows ipl now weaker, page-5
Featured News
Add IPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.03 |
Change
-0.085(2.73%) |
Mkt cap ! $5.751B |
Open | High | Low | Value | Volume |
$3.09 | $3.10 | $3.01 | $72.63M | 23.51M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
83 | 129677 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 176791 | 79 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
83 | 122270 | 3.020 |
19 | 218376 | 3.010 |
16 | 90557 | 3.000 |
11 | 94994 | 2.990 |
9 | 52841 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.030 | 186715 | 90 |
3.040 | 156377 | 15 |
3.050 | 61715 | 13 |
3.060 | 62354 | 12 |
3.070 | 215420 | 11 |
Last trade - 15.54pm 12/11/2024 (20 minute delay) ? |
Featured News
IPL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online